XML 40 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value of Financial Instruments and Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, by Balance Sheet Grouping

Fair value estimates of the Company’s financial instruments as of September 30, 2021 and December 31, 2020, including methods and assumptions utilized, are set forth below:

 

   As of September 30, 2021 
   Carrying                 
   amount   Level 1   Level 2   Level 3   Total 
Financial assets:                         
Cash and cash equivalents  $117,314   $117,314   $-   $-   $117,314 
Investment securities available-for-sale   378,518    40,314    338,204    -    378,518 
Bank stocks, at cost   2,985    n/a    n/a    n/a    n/a 
Loans, net   656,908    -    -    666,080    666,080 
Loans held for sale   8,929    -    8,929    -    8,929 
Accrued interest receivable   4,613    127    1,543    2,943    4,613 
Derivative financial instruments   824    -    824    -    824 
                          
Financial liabilities:                         
Non-maturity deposits  $(957,420)  $(957,420)  $-   $-   $(957,420)
Certificates of deposit   (109,267)   -    (109,328)   -    (109,328)
Subordinated debentures   (21,651)   -    (16,271)   -    (16,271)
Other borrowings   (6,219)   -    (6,219)   -    (6,219)
Accrued interest payable   (135)   -    (135)   -    (135)


 

   As of December 31, 2020 
   Carrying                 
   amount   Level 1   Level 2   Level 3   Total 
Financial assets:                         
Cash and cash equivalents  $84,818   $84,818   $-   $-   $84,818 
Investment securities available-for-sale   297,270    2,037    295,233    -    297,270 
Bank stocks, at cost   4,473    n/a    n/a    n/a    n/a 
Loans, net   702,782    -    -    718,071    718,071 
Loans held for sale   15,533    -    15,533    -    15,533 
Accrued interest receivable   4,885    -    1,697    3,188    4,885 
Derivative financial instruments   1,796    -    1,796    -    1,796 
                          
Financial liabilities:                         
Non-maturity deposits  $(882,277)  $(882,277)  $-   $-   $(882,277)
Certificates of deposit   (133,750)   -    (134,048)   -    (134,048)
Subordinated debentures   (21,651)   -    (15,232)   -    (15,232)
Other borrowings   (6,371)   -    (6,371)   -    (6,371)
Accrued interest payable   (168)   -    (168)   -    (168)
Derivative financial instruments   (466)   -    (466)   -    (466)

Schedule of Fair Value, Assets Measured on Recurring Basis

The following tables represent the Company’s financial instruments that are measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020, allocated to the appropriate fair value hierarchy:

 

(Dollars in thousands)      As of September 30, 2021 
       Fair value hierarchy 
   Total   Level 1   Level 2   Level 3 
Assets:                
Available-for-sale investment securities:                    
U. S. treasury securities  $40,314   $40,314   $-   $- 
U. S. federal agency obligations   17,297    -    17,297    - 
Municipal obligations, tax exempt   140,788    -    140,788    - 
Municipal obligations, taxable   38,988    -    38,988    - 
Agency mortgage-backed securities   133,502    -    133,502    - 
Certificates of deposit   7,629    -    7,629    - 
Loans held for sale   8,929    -    8,929    - 
Derivative financial instruments   824    -    824    - 

 

       As of December 31, 2020 
       Fair value hierarchy 
   Total   Level 1   Level 2   Level 3 
Assets:                
Available-for-sale investment securities:                    
U. S. treasury securities  $2,037   $2,037   $-   $- 
U. S. federal agency obligations   18,924    -    18,924    - 
Municipal obligations, tax exempt   142,676    -    142,676    - 
Municipal obligations, taxable   49,535    -    49,535    - 
Agency mortgage-backed securities   78,638    -    78,638    - 
Certificates of deposit   5,460    -    5,460    - 
Loans held for sale   15,533    -    15,533    - 
Derivative financial instruments   1,796    -    1,796    - 
Liability:                    
Derivative financial instruments   (466)   -    (466)   - 

Schedule of Fair Value Contractual Balance and Gain Loss on Loans Held for Sale

The aggregate fair value, contractual balance (including accrued interest), and gain on loans held for sale were as follows:

   As of   As of 
   September 30,   December 31, 
(Dollars in thousands)  2021   2020 
Aggregate fair value  $8,929   $15,533 
Contractual balance   8,822    15,151 
Gain  $107   $382 

Schedule of Gains and Losses from Changes in Fair Value of Loans Held for Sale

 

  2021   2020   2021   2020 
   Three months ended   Nine months ended 
   September 30,   September 30, 
(Dollars in thousands)  2021   2020   2021   2020 
Total change in fair value  $            (279)  $(315)  $(506)  $1,657 


Schedule of Fair Value Measurements on Nonrecurring, Valuation Techniques

The following table presents quantitative information about Level 3 fair value measurements measured at fair value on a nonrecurring basis as of September 30, 2021 and December 31, 2020.

 

(Dollars in thousands)
   Fair value   Valuation technique  Unobservable inputs  Range 
As of September 30, 2021                
Impaired loans:                
Commercial real estate  $3,695   Sales comparison  Adjustment to appraised value   20%
Commercial   8   Sales comparison  Adjustment to comparable sales   0%-100% 
Agriculture   1,436   Sales comparison  Adjustment to appraised value   0%
Real estate owned:                
Commercial real estate   1,193   Sales comparison  Adjustment to appraised value   0%
                 
As of December 31, 2020                
Impaired loans:                
Commercial real estate  $3,640   Sales comparison  Adjustment to appraised value   20%
Commercial   74   Sales comparison  Adjustment to comparable sales   0%-69% 
Agriculture   9   Sales comparison  Adjustment to appraised value   20%
Real estate owned:                
One-to-four family residential real estate   48   Sales comparison  Adjustment to appraised value   10%